Information PortalData PortalKnowledge Portal

Data Matrix

Tools & Workflows

Documentation

1722.61 (Glytoucan)

Id:4c3e973e-ee1f-5f99-a9d1-45cbfcfc70ea

Glytoucan:G39248DW

Results found

Linked to

	Label	Description
	1722.61 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000027 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1722.61 has glycosequence GLYGEN.GLYCOSEQUENCE:G55462TF-GLYCOSEQ00176186 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1722.61 has glycosequence GLYGEN.GLYCOSEQUENCE:G91089ZR-GLYCOSEQ00170009 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1722.61 has glycosequence GLYGEN.GLYCOSEQUENCE:G24439YF-GLYCOSEQ00135045 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1722.61 has glycosequence GLYGEN.GLYCOSEQUENCE:G04947MP-GLYCOSEQ00094244 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1722.61 has canonical residue n-glycan a-d-manp 24 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1722.61 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000095 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1722.61 has canonical residue n-glycan a-d-manp 19 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1722.61 has glycosequence GLYGEN.GLYCOSEQUENCE:G18650BV-GLYCOSEQ00016208 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1722.61 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000024 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1722.61 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000027 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1722.61 has glycosequence GLYGEN.GLYCOSEQUENCE:G55462TF-GLYCOSEQ00176186 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1722.61 has glycosequence GLYGEN.GLYCOSEQUENCE:G91089ZR-GLYCOSEQ00170009 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1722.61 has glycosequence GLYGEN.GLYCOSEQUENCE:G24439YF-GLYCOSEQ00135045 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1722.61 has glycosequence GLYGEN.GLYCOSEQUENCE:G04947MP-GLYCOSEQ00094244 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1722.61 has canonical residue n-glycan a-d-manp 24

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1722.61 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000095 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1722.61 has canonical residue n-glycan a-d-manp 19

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1722.61 has glycosequence GLYGEN.GLYCOSEQUENCE:G18650BV-GLYCOSEQ00016208 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1722.61 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000024 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025

This repository is under review for potential modification in compliance with Administration directives.